Skip to content

Brief psychological therapy compared to general practitioners care for depression in primary care: a randomised controlled trial

The clinical and functional effectiveness of brief cognitive behavioural therapy compared to general practitioners care for depressive primary care patients: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65811640
Enrollment
122
Registered
2010-06-14
Start date
2007-01-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders Depressive episode

Interventions

General Practitioners Care: The treatment protocol is set up according to The Dutch College of General Practitioners Practice Guideline (NHG- standard) and composed after reviewing the
GP?s can adapt the scheme to their own style or to special circumstances. The treatment consists of supportive contacts which can be combined with an antidepressant agent. The duration of the treatmen

Sponsors

Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 70 years and suffering from major depressive disorder (MDD) determined by an independent researcher with the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)

Exclusion criteria

Exclusion criteria: 1. Suffering (now and in the past as assessed by the SCID-I) from schizophrenia or bipolar disorder 2. Contra-indication for MDD treatment like mental retardation or terminal illness 3. Having trouble with the Dutch or English language 4. Severe suicidal thoughts 5. Receiving an active MDD treatment. Active treatment is defined as: 5.1. Antidepressive medication (except those who receive this in low dosage for pain complaints: Amitriptyline less than 50 mg, Nortriptyline less than 50 mg, bupropion[Zyban®]) 5.2. Psychotherapy 5.3. Supportive visits with the GP or social worker, except for diagnostic visits (less than 2)

Design outcomes

Primary

MeasureTime frame
1. Hamilton depression rating scale-17 by telephone 2. Patient Heath Questionnaire-9: patient rated. Score: 0 (ie, not at all) and 1 (ie, few days) 2 (ie, more than half the days) and 3 (ie, nearly every day) All primary outcomes are assessed at baseline, 6, 12 and 52 weeks.

Secondary

MeasureTime frame
Medical Outcomes Study 36- Item Short Form Health Survey, assessed at baseline, 12 and 52 weeks.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 30, 2026